Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-002620
Filing Date
2014-03-19
Accepted
2014-03-19 14:06:57
Documents
8
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218960z10-k.htm 10-K 1800257
2 EX-23.1 a2218960zex-23_1.htm EX-23.1 3026
3 EX-31.1 a2218960zex-31_1.htm EX-31.1 7658
4 EX-31.2 a2218960zex-31_2.htm EX-31.2 7813
5 EX-32.1 a2218960zex-32_1.htm EX-32.1 4329
6 EX-32.2 a2218960zex-32_2.htm EX-32.2 4330
7 G701126.JPG g701126.jpg GRAPHIC 89884
8 G121521.JPG g121521.jpg GRAPHIC 76197
  Complete submission text file 0001047469-14-002620.txt   2057501
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36208 | Film No.: 14703669
SIC: 2834 Pharmaceutical Preparations